Report - National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV. Brzo sc konver- tuje u metabolit hydrodolasetron, koji se pokazao

Please pass captcha verification before submit form